Novel treatment modalities in erectile dysfunction
The objective of this e-course is to provide an update on new modalities of ED-treatment such as stem cell therapy, extracorporeal shock wave treatment, and platelet-rich plasma usage.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 70 minutes |
Considering that a subpopulation of men with erectile dysfunction (ED) is unresponsive to Phosphodiesterase-5 (PDE5) inhibitors, it appears that novel modes of treatments for ED are of paramount importance.
This e-course will answer questions raising theses and antitheses concerning their efficiency, safety, or genetic, and epigenetic risks.
Furthermore, the experts will discuss the current EAU Guidelines and their underlying rationale for the pharmaceutical or surgical treatment of Peyronie’s disease.
Speakers:
Prof. Dr. J. Rassweiler (DE)
Prof. N. Sofikitis (GR)
Dr. M. Benyó (HU)
Prof. A. Kadioglu (TR)
This e-course is brought to you in collaboration with ESUO-ESAU.